The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -5.93 — distress zone — historically elevated failure riskWatch
Where the revenue comes from
Fiscal 2025, as PROTHENA CORP PUBLIC LTD CO reports it. History and quarterly detail are in the app.
- Collaboration revenue$9.6M
- Collaboration Program, Global, PRX019$9.6M
- Revenue from license and intellectual property$50K
Leadership changes
From PROTHENA CORP PUBLIC LTD CO's own filings, the day they're filed.
- Hideki Garren · Chief Medical Officer · departureeff. 2024-09-27
- Daniel G. Welch · director · appointmenteff. 2024-02-21
- William H. Dunn Jr · appointmenteff. 2023-05-16
Latest filings
- 8-K · Company announcement2026-05-15
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
- DEF 14A · Annual proxy (pay & governance)2026-03-27
- 8-K · Company announcement2026-02-27
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about PROTHENA CORP PUBLIC LTD CO, every answer cited🔒
- The Intelligence Brief — added when PROTHENA CORP PUBLIC LTD CO's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.